Key facts
- Notable investors include Sinopharm CICC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Guangzhisuoji Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Guangzhisuoji Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guangzhisuoji Medical
Manufacturer of soft hydrophilic lens technologies intended for ophthalmic and vision correction purposes. The company offers material innovation, comfort optimization, and safety enhancement through advanced polymer engineering and biocompatibility testing, enabling the medical and consumer eye care markets to access contact lens solutions that offer improved wearability, reduced irritation, and functional adaptability to diverse ocular conditions and usage environments.
- Sector
- Business Products and Services (B2B)
- HQ
- Nanchang, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Guangzhisuoji Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guangzhisuoji Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guangzhisuoji Medical in its N-PORT filings yet. We sweep new filings monthly.